Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ivabradine and Metoprolol on Central Arterial Pressure
NCT00825123Phase 4Terminated
- Start
- Oct 2008
- Primary completion
- Nov 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ivabradine in hypertension (HTN) (3 arms). Primary endpoint: Central Arterial Pressure at 4 hours. Started Oct 2008; status: terminated.
02
Drugs
ivabradine
03
Conditions
hypertension (HTN)
Beyond the preview
Go deeper on NCT00825123.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00825123.